Price target
129.380.000.00%
The 8 analysts offering 1 year price forecasts for LGND have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to LGND in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
LGND EPS for the last quarter is 1.40 USD despite the estimation of 1.06 USD. In the next quarter EPS is expected to reach 1.35 USD. Track more of Ligand Pharmaceuticals Incorporated financials and stay on top of what is up with the company.
In the next quarter Ligand Pharmaceuticals Incorporated revenue is expected to reach 40.60 M USD. Check out Ligand Pharmaceuticals Incorporated revenue and earnings and make informed decisions.
According to analysts, LGND price target is 129.38 USD with a max estimate of 157.00 USD and a min estimate of 110.00 USD. Check if this forecast comes true in a year, meanwhile watch Ligand Pharmaceuticals Incorporated stock price chart and keep track of the current situation with LGND news and stock market news.
We've gathered opinions of 7 analysts rating LGND stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.